Author Archives: Pharmacy Admin

Dr. Mandip Sachdeva Receives Consortium for Medical Marijuana (MMJ) Clinical Outcomes Research Grant
24 Feb

Dr. Mandip Sachdeva Receives Consortium for Medical Marijuana (MMJ) Clinical Outcomes Research Grant

Florida A&M University College of Pharmacy & Pharmaceutical Sciences, Institute of Public Health (FAMU CoPPS, IPH), Pharmaceutical Sciences Professor, Mandip Sachdeva, Ph.D., was recently awarded funding for his grant proposal entitled “Hyaluronic acid-functionalized, Cannabidiol-loaded Mesenchymal Stem Cells (MSC)-Derived Exosomes for Drug-Resistant Cancers” through the Consortium for Medical Marijuana (MMJ) Clinical Outcomes Research Grants Program.  

The Consortium for Medical Marijuana Clinical Outcomes Research, which is composed of public and private universities, engaged in research on clinical outcomes of medical marijuana. The consortium will evaluate the safety and effectiveness of medical marijuana, consider dosing and routes of administration, including the study of the effects of smoking medical marijuana versus other methods of consumption. 

Funding recommendations were made after thoughtful and careful consideration at the MMJ Clinical Outcomes Consortium Research Board meeting in Fall 2019. Out of 41 proposal submissions by investigators from different consortium member institutions for the 2019 funding cycle, Dr. Sachdeva’s proposal was one of the ten that was chosen. His proposal for $71,250 was approved for the period of December 1, 2019, through July 31, 2020.   

“We would like to applaud Dr. Sachdeva for his excellent grantsmanship and significant accomplishment in securing extramural funding,” said Associate Dean of Pharmaceutical Sciences, Selina Darling-Reed, Ph.D. “His continued excellence is an inspiration to us all.” 

FAMU COPPS, IPH CPE Program Is Reaccredited and Continues to Deliver  Exceptional CPE Programs
11 Feb

FAMU COPPS, IPH CPE Program Is Reaccredited and Continues to Deliver Exceptional CPE Programs

The Florida A&M University College of Pharmacy & Pharmaceutical Sciences, Institute of Public Health’s (FAMU CoPPS, IPH) Office of Continuing Pharmacy Education (CPE) has been reaccredited by Accreditation Council for Pharmacy Education (ACPE), through January 31, 2025. The CPE program is led by Selika Stackhouse Sampson, PharmD., interim director of Continuing Pharmacy Education.

The goal of the CPE program is to provide general and consultant continuing education for pharmacists and pharmacy technicians through a series of live programs to serve as a center of life-long learning. The CPE program aids the college with strengthening alumni affairs, provides networking opportunities for pharmacists, pharmacy technicians, and student learners.

ACPE’s Continuing Education Provider Accreditation Program is designed to assure pharmacists, boards of pharmacy, and other members of the pharmacy’s community of interests, of the quality of continuing pharmacy education programs. CPE providers must show compliance with the Standards and Policies outlined by ACPE. FAMU CoPPS CPE office had to demonstrate adherence to the Standards and Policies.

To achieve reaccreditation, the FAMU CoPPS CPE office formed a committee comprised of faculty, staff, and learners from all divisions of the CoPPS, IPH. The committee members completed a self-assessment, which included CPE program data and samples of the college’s CPE programs. An interim report of their findings was submitted to ACPE.

“Dr. Selika Sampson and the CPE team are to be commended for their awesome work, dedication, and commitment in submitting a well-organized interim report and for moving our CPE program to the next level. Job well done!” said Jocelyn D. Spates, PharmD., CoPPS associate dean of Clinical Affairs.

“We are pleased to have earned reaccreditation by ACPE and to share in our success with the College,” said Dr. Sampson. “Reaccreditation confirms and validates the work we do to ensure top-quality CPE programs for pharmacists and technicians.”

FAMU/BMS Welcomes the 2020 Resident Cohort
07 Feb

FAMU/BMS Welcomes the 2020 Resident Cohort

Florida A&M University College of Pharmacy & Pharmaceutical Science, Institute of Public Health (FAMU CoPPS, IPH), welcomes two new residents.  Raena D. Rhone, PharmD, from Chicago, IL, and Franko Dickson, PharmD, from Accra, Ghana, will be furthering their postgraduate pharmacy training with the FAMU/Bristol-Myers Squibb (BMS) partnership. 

This pharmaceutical industry residency program was founded in 2009 as a partnership between FAMU and Bristol-Myers Squibb. The vision of the residency is to attract and develop a diverse group of talented pharmacists who bring clinical expertise, innovative ideas, and dedication to improving patient outcomes. The program provides a two-year residency in the therapeutic area of oncology. This residency will provide the residents with a unique experience that bridges the gap between clinical practice and the pharmaceutical industry.

Dr. Rhone received a PharmD from the University of North Carolina, Eshelman School of Pharmacy, in Chapel Hill, North Carolina.  When asked what drew her to the FAMU/BMS residency program, she said, “When pursuing a postgraduate training program, I was looking for three main qualities. First, I wanted to pursue a program that would help me to build my clinical skillset so that I could become an effective Medical Science Liaison (MSL) in the future. While there are MSL fellowships available, having a solid clinical foundation is a key to success in this career path. Second, I wanted to be a part of a program where I would have strong mentors to help guide me on my professional journey. With the FAMU/BMS Residency Program, I am confident that I will not only gain professional mentors in the pharmaceutical industry but will also gain mentors in academia and clinical pharmacy. Finally, after being a Hematology and Oncology intern at the University of North Carolina Cancer Hospital, I am most passionate about serving patients battling cancer. I wanted to gain industry experience at a company that was strong in Oncology and Hematology. With BMS’s recent acquisition of Celgene, I could not have asked for a better company to be a part of.”

Dr. Dickson, who received a PharmD from Western University of Health Sciences in Pomona California, said,  “The main thing that drew me to the program was its unique structure. It offers clinical, industrial, and academic experience, a trifecta of experience that no other program offers. These experiences will definitely equip me with the requisite knowledge and skills to forge a successful career as a pharmacist. I am super excited to start and looking forward to meeting the entire FAMU/BMS team. I am also looking forward to the experiences and memories that I am about to make in this program.”

“During the interview process, we had approximately 28 applicants. The two learners chosen did their research. They were excellent,” said Nathaniel E. Eraikhuemen, PharmD, Division Director & Associate Professor at the CoPPS Davie, Florida Instructional Site.

 “I trust they will be very successful in the program. The FAMU/BMS residency is the only pharmacy residency program that compounds both clinical and industry training. We look forward to having this astute cohort of learners.” 

The new cohort will start their pharmaceutical industry residency in June 2020. To learn more about FAMU/BMS postgraduate training, visit

FAMU College of Pharmacy Alumnus Receives Surprise Visit From Oprah at His Charlotte Pharmacy
06 Feb

FAMU College of Pharmacy Alumnus Receives Surprise Visit From Oprah at His Charlotte Pharmacy

Florida A&M University (FAMU) College of Pharmacy and Pharmaceutical Sciences (COPPS) graduate Martez Prince, PharmD, is basking in the afterglow of Oprah’s seal of approval.

The media mogul paid a surprise visit to Prince’s Charlotte, N.C., pharmacy, Premier Pharmacy and Wellness Center, as part of her tour her “2020 Vision Tour: Your Life in Focus,” which is presented in partnership with WW (formerly Weight Watchers).

“It’s definitely one of those moments,” said Prince, who grew up in Fort Pierce, Fla. The 2010 graduate of the COPPS Institute of Public Health said it has taken a week for the impact of his Oprah encounter to sink in.  “It’s an amazing experience. To have that moment is surreal and very powerful,” he said.

The occasion was Prince’s 6th Wellness Fair and Celebration. The pharmacy usually hosts the fair in September; however, Oprah’s attendance was a special occasion. The fair featured local dentists, chiropractors, and more. The goal is to help the community establish the habit of regular checkups.

Prince’s work got Oprah’s attention because he is a minority-owned business that demonstrates a significant impact on the community in the area of health and wellness.

Prince said Oprah’s visit confirms he is doing the right thing. He said the wellness fair attendees were excited and empowered,

“The fact that Oprah dropped in on the event and talked about health and wellness was a big deal,” Prince said. “She demonstrated wellness could be a celebration.”

Oprah said she was impressed by Prince’s courage and determination to leave a corporate pharmacy and open his own business to improve the health of his community.

“Premier Pharmacy is not just an advantage and a great offering for this community. It’s a model for the country,” Oprah said at the event.

Dean Johnnie Early, Ph.D., said Prince is a fine example of what FAMU alumni can accomplish.

“We are inspired to see one of our COPPS, IPH graduates showing vision and entrepreneurship in the area of health and wellness,” said Early. “In providing community focused pharmacy care, Dr. Prince has set a standard for others to follow. And to be highlighted by Oprah is a testament to what he has accomplished in just a decade since graduation.” 

On October 3, 2015, Prince established Premier Pharmacy and Wellness Center, which is solely focused on the holistic wellbeing of its community. He started the business to give people from underserved communities a deeper understanding of their medication and healthcare. Staffed by 10 employees, Premier Pharmacy also houses a walk-in clinic run by a family nurse practitioner who can provide health screenings, vaccines, and acute care services like allergy treatments.

In the week since Oprah’s visit and the show aired, Prince has seen a flurry of media coverage, social media buzz and new business.

“We’ve gotten people who have transferred their prescriptions to us and using our services,” he said.

FAMU COPPS/IPH Alumnus Accepts New Position as Associate Professor at the University of Kentucky
03 Feb

FAMU COPPS/IPH Alumnus Accepts New Position as Associate Professor at the University of Kentucky

Dr. Daniel C. Lee was recently appointed as an Associate Professor in the Department of Neuroscience and Sanders-Brown Center of Aging in the College of Medicine at the University of Kentucky in Lexington, KY. Dr. Dan Lee became a faculty member at the University of Kentucky in August 2019. 

Dr. Dan Lee is a 2005 graduate of the Florida A&M University College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health doctoral program. His area of concentration while matriculating in the pharmaceutical sciences graduate program was pharmacology, more specifically, neuropharmacology. Dr. Lee has agreed to serve as a mentor to fellows participating in the FAMU CREATE Program. The Center for Research Education and Training Enhancement (CREATE) Program at FAMU is a national program that accepts scholars (Ph.D. students and early-career investigators) seeking to increase the quality of their research education. 

Dr. Lee is an accomplished researcher in the field of pharmaceutical sciences. His research focuses on how substances that cause inflammation in the brain may contribute to Alzheimer’s and Parkinson’s diseases. He is a founding faculty member of the University of Florida College of Pharmacy. He currently serves as a grant reviewer for the Alzheimer’s Association. He is the recipient of an NIH/NIA (National Institute of Health/National Institute of Aging) R01 grant titled, “Emerging Roles of Higher-order Polyamines During Tauopathies” and an NIH/NIA R21 grant titled “Understanding the Role GPRC6a During Tau Metabolism”. 

Dr. Lee will visit and present his research at the CoPPS, April 9, 2020, during the graduate seminar series. 

FAMU COPPS-IPH Students Recognized at the NanoFlorida International Conference
16 Jan

FAMU COPPS-IPH Students Recognized at the NanoFlorida International Conference

In November 2019, Florida A&M University (FAMU) College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health (CoPPS, IPH), attended the 2019 NanoFlorida International Conference at the University of South Florida in Tampa, Florida. 

The NanoFlorida International Conference is a unique event that provides an opportunity for undergraduate and graduate students to learn about the futuristic applications of Nanotechnology in the clinical and basic pharmaceutical sciences. This year’s theme was “Advances in Translational Nanobiotechnology.” 

The conference provided opportunities for students to network with Florida’s leading academic institutions and the broad nanobiotechnology industry. It offers a platform for collaborative and interdisciplinary research. 

CoPPS Ph.D. students participated in the poster and oral presentations with over 200 poster presenters from various universities across the United States. FAMU CoPPS students were recognized for their exceptional research. The student poster presentation titles include,

  • “3D Printed Tumor Spheroids for Disease Modeling and Chemotherapeutic Drug Screening” by Aragaw Gebeyehu
  • “High-Throughput 3D Printing of Corneal Equivalents” by Shallu Kutlehria
  • “The Anticancer Efficacy of the Combinational Treatment of Docetaxel Loaded Pegylated Liposomes and a Tumor Stromal Disrupting Agent in Lung Cancer” by Peggy Arthur. 

“The Nanoflorida International Conference 2019 was very insightful. I had the opportunity to learn and share ideas with researchers in the field of nanotechnology and drug discovery from different research institutes across the world,” said Pharmaceutics Ph.D. candidate, Peggy Arthur. 

Pharmaceutics Ph.D. candidate, Shallu Kutlehria, said, “Graduate students must attend this conference as it is a huge platform for networking, sharing knowledge about ongoing research and challenges in drug development, and nanotechnology. It is a great opportunity to get new ideas and suggestions from peers”.

CoPPS Ph.D. students, Arthur, Kutlehria, and Gebeyehu, all received certificates of distinction and were recognized on stage for their presentations.

Trividia Donates Glucose Monitors to Assist With Student Training and Health Fairs
16 Jan

Trividia Donates Glucose Monitors to Assist With Student Training and Health Fairs

Trividia Health, Inc., an innovative company that specializes in the development of blood glucose monitors and other diagnostic devices, donated 125 glucose monitors and accompanying test strips to the Florida A&M University (FAMU) College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health (CoPPS, IPH). These glucose monitors will contribute to learner training and support the free health fairs sponsored by the College.

To increase student understanding of how to effectively use glucose monitors, Gail Amato, Trividia National Account Manager, and Rhonda Lemmo, MBA, RN, CNOR, Sr. Director of Clinical Marketing, will provide an in-service at the College in February for student pharmacists registered for the Pre-APPE Readiness course. Pre-APPE Readiness is an academic course in the third professional year, which examines the feasibility of student preparedness for advanced pharmacy practice experiences.

With more than 30 years of experience in the blood glucose monitoring market, Trividia is fully committed to effective diabetes management and improved patient adherence, awareness, and compliance. Trividia’s blood glucose testing meters and strips, marketed under the TRUE METRIX® brand, have preferred contracted access to monitor more than 45 million diabetics. Additionally, the company offers a full array of sharps, including lancets, insulin syringes, and pen needles. 

The College is elated about this new partnership with Trividia says, Marlon S. Honeywell, PharmD., CoPPS executive dean, and professor. “Their vital donation and assistance with training will aid CoPPS learners with comprehension of and respect for the various complexities associated with diabetes monitoring and control.”

CoPPS-IPH Staff Member to Celebrate 23 Years of Performing at the FAMU MLK Convocation
15 Jan

CoPPS-IPH Staff Member to Celebrate 23 Years of Performing at the FAMU MLK Convocation

Florida A&M University (FAMU) College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health (CoPPS, IPH) Director of Alumni Engagement, James L. Moran, Jr., will perform a rendition of “I Have a Dream” by  Dr. Martin Luther King Jr. at the  FAMU Dr. Martin Luther King, Jr. Convocation this Thursday, January 16, 2020.

This year marks the 23rd year that Dr. Moran has performed the speech for convocation. He fell upon the roll during a break backstage of a play at the FAMU Essential Theatre. During that break, Dr. Moran playfully impersonated Dr. King, and a crew member shouted, “You sound just like Dr. King! You should audition your rendition of the speech for the Marching 100 directors for convocation.” Dr. Moran followed through with that suggestion. He received an audiotape of “America the Beautiful”, performed by the Marching 100 and he practiced the MLK Jr. speech over the audio until the piece had been memorized.

In June 1996, Marching 100 directors, William P. Foster, Ed.D., and Julian White, Ph.D., chose Dr. Moran to perform the speech and his first performance was at convocation on January 9, 1997.

Since his first performance in 1997, Dr. Moran has performed the speech in front of government dignitaries, military personnel, at state prisons, churches, and at competitions with the Marching 100. This year, in addition to performing at convocation, Dr. Moran will deliver the speech on Friday, January 15, at the Tallahassee Branch of the NAACP, MLK Leadership Breakfast, and Trinity United Presbyterian Church of Tallahassee. On Monday, January 20, he will perform during the Tallahassee Branch of the NAACP MLK Citywide March and program, which will be held at the State Capitol.

The FAMU-CoPPS Is Empowering Learner Success on Upcoming NAPLEX® Exam
09 Jan

The FAMU-CoPPS Is Empowering Learner Success on Upcoming NAPLEX® Exam

Between May 1, 2019, and August 31, 2019, Florida A&M University (FAMU) College of Pharmacy and Pharmaceutical Sciences (CoPPS) learners who took the North American Pharmacist Licensure Examination® (NAPLEX®) for the first time had an 83.65 percent pass rate. This pass rate represented an increase of approximately eight percentage points over the 2018 results.

The NAPLEX® measures a candidate’s knowledge of the practice of pharmacy. The exam is developed by the National Association of Boards of Pharmacy. It is one component used by the state boards of pharmacy for assessing a candidate’s ability to practice pharmacy.

The CoPPs has invests approximately $75 – $100K per year (depending on the class size) in resources to help P4 learners succeed on the NAPLEX.  P4 learners are required to pass the NAPLEX with 75% or better and they have up to 5 attempts to pass the exam. The College’s goal is to maintain a high percentage pass rate for first-time test-takers.

Some of the resources provided by the College before the exam include a study guide for P4 learners enrolled in Clinical Seminar and Research Methods I, II, and III courses. The learners are required to take monthly cumulative examinations per the study guide.

The College has also partnered with RxPrep. RxPrep is the leading provider of Pharmacy licensure study materials written by expert Pharmacists. The company designs, develops, and supports a desktop and mobile application for exam preparation and skill-building for healthcare professionals and universities.

From March 30, 2020, to April 2, 2020, RxPrep NAPLEX® review instructors will visit the Tallahassee campus to conduct a three-day intensive NAPLEX® licensure review session with P4 learners. This review session is from 8a-5pm, and the learners utilize their RxPrep coursebook and online access to study materials. The RxPrep instructor will present a variety of crucial exam topics with quick subject reviews, in combination with integrated patient cases. Learners will respond to case questions, and the learner’s responses will enable the instructor to assess whether more or less time is required for reach topic. Following the live review, the learners engage in a self-directed study for the remainder of the month.

After graduation, the College provides a one-time Pre-NAPLEX® voucher. The Pre-NAPLEX® prepares you for the NAPLEX testing experience as learner’s field questions similar to those they will face on the day of the test. The cost of each voucher is $65.  Learners may take the Pre-NAPLEX twice.

The College is committed to providing these invaluable resources to our learners. We are definitely excited about the return on our investment said Jocelyn D. Spates, PharmD., FAMU-CoPPS Associate Dean of Clinical Affairs. Dr. Spates serves on the University’s Licensure Pass Rate Task Force chaired by Provost Maurice Edington, Ph.D.

Currently, the NAPLEX® national average for first-time candidates is 90.59 percent; the state average is 86.96 percent.